skip to main content

Healthcare Private Equity

The firm serves as sophisticated legal advisors to private equity funds, their portfolio companies, and healthcare providers engaging in private equity transactions. We understand the critical balance between achieving financial returns and ensuring strict compliance with the complexities of healthcare laws and regulations, utilizing our expertise in corporate law, mergers and acquisitions, healthcare regulatory compliance, and litigation to provide comprehensive support throughout the entire investment lifecycle.

We provide guidance on investment and financing activities within the healthcare sector, including deal structuring and regulatory due diligence, growth investments and buy-and-build strategies, control, non-control and minority investments, buy-outs and recapitalizations, strategic dispositions and exit strategies, and bankruptcy, restructurings and workouts. Our attorneys also serve as general counsel for portfolio companies, advising on significant transactions as well as day-to-day legal matters, and providing efficiency and continuity for platform acquisitions, bolt-on transactions, ownership and operational issues, regulatory compliance matters, and sales.

Representative Matters

  • Advised a private equity client in the acquisition and subsequent exit from an urgent care practice, successfully extracting the client near its original investment with full indemnification after operational failures.
  • Represented a private investment fund in a CPA firm’s acquisition of a medical coding company, navigating complex cross-border regulatory requirements involving India-based ownership.
  • Advised a medical electronic billing company in its $22 million sale (plus earn-out) to a national healthcare services provider.
  • Advised a medical practice in a Chapter 11 bankruptcy proceeding involving competing claims from a private equity sponsor, an acquisition lender, and the practice’s physician owners. The matter addressed disputes arising from the dissolution of the practice, restrictive covenant issues, and claims exceeding $35 million. The firm guided the parties to a global settlement and confirmation of a Chapter 11 plan of liquidation, resolving all claims.

Of Interest